Gut Liver.  2021 Jul;15(4):616-624. 10.5009/gnl20214.

Risk Factors for Acute Cholangitis Caused by Enterococcus faecalis and Enterococcus faecium

Affiliations
  • 1Department of Gastroenterology, Mitsui Memorial Hospital, Tokyo, Japan.
  • 2Center of Endoscopy, Mitsui Memorial Hospital, Tokyo, Japan.
  • 3Department of Gastroenterology, Chiba University Hospital, Chiba, Japan.
  • 4Center of Endoscopy, Chiba University Hospital, Chiba, Japan.
  • 5Department of Gastroenterology, University of Tokyo Hospital, Tokyo, Japan.

Abstract

Background/Aims
Acute cholangitis (AC) is a potentially life-threatening bacterial infection, and timely antimicrobial treatment, faster than that achieved with bacterial cultures, is recommended. Although the current guidelines refer to empirical antimicrobial treatment, various kinds of antimicrobial agents have been cited because of insufficient analyses on the spectrum of pathogens in AC. Enterococcus spp. is one of the most frequently isolated Gram-positive bacteria from the bile of patients with AC, but its risk factors have not been extensively studied. This study aimed to analyze the risk factors of AC caused by Enterococcus faecalis and Enterococcus faecium.
Methods
Patients with AC who were hospitalized in a Japanese tertiary center between 2010 and 2015 were retrospectively analyzed. Patients’ first AC episodes in the hospital were evaluated.
Results
A total of 266 patients with AC were identified. E. faecalis and/or E. faecium was isolated in 56 (21%) episodes of AC. Prior endoscopic sphincterotomy (EST), the presence of a biliary stent, prior cholecystectomy, and past intensive care unit admission were more frequently observed in AC patients with E. faecalis and/orE. faecium than in those without such bacteria. Prior EST was identified as an independent risk factor for AC caused by E. faecalis and/or E. faecium in the multivariate analysis.
Conclusions
Given the intrinsic resistance of E. faecalis and E. faecium to antibiotics, clinicians should consider empirical therapy with anti-enterococcal antibiotics for patients with prior EST.

Keyword

Cholangitis; Enterococcus; Sphincterotomy; Anti-microbial agents; Therapeutics
Full Text Links
  • GNL
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr